ELVN
Price
$18.63
Change
+$0.36 (+1.97%)
Updated
May 8 closing price
Capitalization
914.1M
90 days until earnings call
THAR
Price
$1.50
Change
-$0.04 (-2.60%)
Updated
May 8, 04:58 PM (EDT)
Capitalization
3.14M
Ad is loading...

ELVN vs THAR

Header iconELVN vs THAR Comparison
Open Charts ELVN vs THARBanner chart's image
Enliven Therapeutics
Price$18.63
Change+$0.36 (+1.97%)
Volume$412.96K
Capitalization914.1M
Tharimmune
Price$1.50
Change-$0.04 (-2.60%)
Volume$200
Capitalization3.14M
ELVN vs THAR Comparison Chart
Loading...
ELVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
THAR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ELVN vs. THAR commentary
May 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ELVN is a Hold and THAR is a Hold.

Ad is loading...
COMPARISON
Comparison
May 09, 2025
Stock price -- (ELVN: $18.63 vs. THAR: $1.49)
Brand notoriety: ELVN and THAR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ELVN: 138% vs. THAR: 40%
Market capitalization -- ELVN: $914.1M vs. THAR: $3.14M
ELVN [@Biotechnology] is valued at $914.1M. THAR’s [@Biotechnology] market capitalization is $3.14M. The market cap for tickers in the [@Biotechnology] industry ranges from $301.75B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ELVN’s FA Score shows that 0 FA rating(s) are green whileTHAR’s FA Score has 0 green FA rating(s).

  • ELVN’s FA Score: 0 green, 5 red.
  • THAR’s FA Score: 0 green, 5 red.
According to our system of comparison, both ELVN and THAR are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ELVN’s TA Score shows that 5 TA indicator(s) are bullish while THAR’s TA Score has 6 bullish TA indicator(s).

  • ELVN’s TA Score: 5 bullish, 4 bearish.
  • THAR’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, THAR is a better buy in the short-term than ELVN.

Price Growth

ELVN (@Biotechnology) experienced а -6.15% price change this week, while THAR (@Biotechnology) price change was -3.87% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.66%. For the same industry, the average monthly price growth was +15.23%, and the average quarterly price growth was -12.40%.

Reported Earning Dates

ELVN is expected to report earnings on Aug 07, 2025.

THAR is expected to report earnings on Mar 26, 2025.

Industries' Descriptions

@Biotechnology (-3.66% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ELVN($914M) has a higher market cap than THAR($3.14M). ELVN YTD gains are higher at: -17.200 vs. THAR (-24.138). THAR has higher annual earnings (EBITDA): -10.84M vs. ELVN (-104.24M). ELVN has more cash in the bank: 313M vs. THAR (4.77M). ELVN has less debt than THAR: ELVN (0) vs THAR (560K). ELVN (0) and THAR (0) have equivalent revenues.
ELVNTHARELVN / THAR
Capitalization914M3.14M29,090%
EBITDA-104.24M-10.84M962%
Gain YTD-17.200-24.13871%
P/E RatioN/A0.02-
Revenue00-
Total Cash313M4.77M6,556%
Total Debt0560K-
TECHNICAL ANALYSIS
Technical Analysis
ELVNTHAR
RSI
ODDS (%)
Bullish Trend 1 day ago
78%
Bearish Trend 2 days ago
86%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 2 days ago
84%
MACD
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 2 days ago
83%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 2 days ago
73%
Advances
ODDS (%)
Bullish Trend 7 days ago
82%
Bullish Trend 3 days ago
84%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 7 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
74%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 2 days ago
81%
View a ticker or compare two or three
Ad is loading...
ELVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
THAR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MTNB0.710.07
+11.39%
Matinas Biopharma Holdings Inc
CAKE50.110.61
+1.23%
Cheesecake Factory
PAYC228.670.88
+0.39%
Paycom Software
NPK81.27-0.19
-0.23%
National Presto Industries
BW0.42-0.02
-5.57%
Babcock & Wilcox Enterprises

THAR and

Correlation & Price change

A.I.dvisor indicates that over the last year, THAR has been closely correlated with INSM. These tickers have moved in lockstep 74% of the time. This A.I.-generated data suggests there is a high statistical probability that if THAR jumps, then INSM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To THAR
1D Price
Change %
THAR100%
-6.67%
INSM - THAR
74%
Closely correlated
+0.60%
RAIN - THAR
52%
Loosely correlated
+17.17%
CMND - THAR
50%
Loosely correlated
N/A
SNGX - THAR
46%
Loosely correlated
+4.24%
AGIO - THAR
37%
Loosely correlated
-0.35%
More